Skip to main content

Asset Dedication, LLC

SEC CIK
0001475896
Latest filing
Jul 30, 2026

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by Asset Dedication, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings

Shares (Q1 2025)
0
Sold out in Q1 2025
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q3 2024
Holdings of CRNX by Asset Dedication, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20250$00.0%−305−100.0%Sold outHolders
Q4 2024305$15.6K<0.1%00.0%UnchangedHolders
Q3 2024305$15.6K<0.1%+305NewHolders